Xencor, Inc. (XNCR) Investor Relations Documents

Xencor, Inc. (XNCR) investor relations documents from the company's IR site: 2 presentations, 38 press releases; latest deck 2026-08-06. Read in-app with summaries. First-party data.

Corporate Presentation - August 2026: Xencor's August 2026 update highlights its XmAb® platform, a pipeline of T-cell engagers and antibodies for oncology and autoimmune diseases, and ~$486.4M cash. Key readouts are

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06PresentationCorporate Presentation - August 2026
2026-08-05Press releasePDF Version
2026-08-05Press releaseXencor Reports Second Quarter 2026 Financial Results
2026-07-29Press releasePDF Version
2026-07-29Press releaseXencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter
2026-07-17Press releasePDF Version
2026-07-17Press releaseXencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear
2026-05-06Press releasePDF Version
2026-05-06Press releaseXencor Reports First Quarter 2026 Financial Results
2026-05-05PresentationResults from Phase 1 Study of XmAb942 & TL1A Pipeline Update
2026-05-04Press releasePDF Version
2026-05-04Press releaseXencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW
2026-03-04Press releasePDF Version
2026-03-04Press releaseXencor Announces Change to Ultomiris® Royalty Revenue Forecast
2026-02-25Press releasePDF Version
2026-02-25Press releaseXencor Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-23Press releasePDF Version
2026-02-23Press releaseXencor to Participate at Upcoming Investor Conferences
2026-01-08Press releasePDF Version
2026-01-08Press releaseXencor Highlights Corporate Priorities and 2026 Pipeline Milestones
Press releaseXencor Reports Second Quarter 2025 Financial Results
Press releaseXencor Reports First Quarter 2025 Financial Results
2025-02-27Press releasePDF Version
2025-02-27Press releaseXencor Reports Fourth Quarter and Full Year 2024 Financial Results
2024-11-06Press releasePDF Version
2024-11-06Press releaseXencor Reports Third Quarter 2024 Financial Results
2024-09-06Press releasePDF Version
2024-08-05Press releasePDF Version
2024-08-05Press releaseXencor Reports Second Quarter 2024 Financial Results
2024-05-09Press releasePDF Version
2024-05-09Press releaseXencor Reports First Quarter 2024 Financial Results
2024-02-27Press releasePDF Version
2024-02-27Press releaseXencor Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-20Press releasePDF Version
2023-11-07Press releasePDF Version
2023-11-07Press releaseXencor Reports Third Quarter 2023 Financial Results
2023-08-03Press releaseXencor Reports Second Quarter 2023 Financial Results
2023-03-14Press releasePDF Version
2022-11-07Press releaseXencor Reports Third Quarter 2022 Financial Results
2022-08-03Press releaseXencor Reports Second Quarter 2022 Financial Results

XNCR overview · XNCR earnings · XNCR financials · XNCR KPIs · XNCR documents · XNCR ownership · XNCR peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.